(Q33761099)

29 July 2017

1 reference

title

Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications (English)

1 reference

29 July 2017

Bradford WD

1

1 reference

29 July 2017

Chen J

series ordinal

2

1 reference

29 July 2017

Krumholz HM

series ordinal

3

1 reference

29 July 2017

1 March 1999

1 reference

29 July 2017

1 reference

29 July 2017

15

1 reference

29 July 2017

257-268

1 reference

29 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199915030-00005

29 July 2017

0 references

cites work

Physician use of beta-adrenergic blocking therapy: a changing perspective

1 reference

12 December 2020

Clinical trials versus clinical practice in the secondary prevention of myocardial infarction

1 reference

12 December 2020

Audit of secondary prophylaxis after myocardial infarction

1 reference

12 December 2020

Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home

1 reference

12 December 2020

Are beta-blockers really underutilized in postinfarction patients?

1 reference

12 December 2020

Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992.

1 reference

12 December 2020

Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction

1 reference

12 December 2020

Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators

1 reference

12 December 2020

Beta-blockers in hypertensive and coronary heart disease

1 reference

12 December 2020

Cost-effectiveness of accepted measures for intervention in coronary heart disease.

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience

1 reference

12 December 2020

International beta-blocker review in acute and postmyocardial infarction

1 reference

12 December 2020

Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project.

1 reference

12 December 2020

Regional Variation across the United States in the Management of Acute Myocardial Infarction

1 reference

12 December 2020

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

12 December 2020

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

1 reference

12 December 2020

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction

1 reference

12 December 2020

Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989)

1 reference

12 December 2020

Effect of propranolol in myocardial infarction

1 reference

12 December 2020

Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction

1 reference

12 December 2020

Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate

1 reference

12 December 2020

Beta blocker use in the treatment of community hospital patients discharged after myocardial infarction

1 reference

12 December 2020

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

1 reference

12 December 2020

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

12 December 2020

Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting Physician

1 reference

12 December 2020

Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly

1 reference

12 December 2020

Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials

1 reference

12 December 2020

Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice

1 reference

12 December 2020

Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?

1 reference

12 December 2020

10.2165/00019053-199915030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference